BioSpace News Archive

Top International Cannabis Business Leaders to Speak on Cannabis, the Fastest Growing Market in the World

Total net product sales of $3,890 million, increased 18% Y/Y

Investment round led by founding investors, OrbiMed Israel and OrbiMed US, and Longitude Capital, with participation by RA Capital Management and Pontifax

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Bristol-Myers Squibb (NYSE: BMY) has dosed the first subject in a clinical trial evaluating the safety, pharmacokinetics and pharmacodynamics of BMS-986179

Interim analysis showed statistically significant reductions in liver enzymes, including ALT and AST, measured from baseline at six months

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today the launch of version 4.1 of its award-winning Dario® App for the Dario Blood Glucose Monitoring System

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its Executive Chairman, Leonard Mazur, will present at the Dawson James 2018 Small Cap Growth Stock Conference.

DXC Technology today announced the opening of the DXC Digital Innovation Lab in Singapore.

The win in the patent litigation strengthen Orexo’s long term business opportunities

Nordic Nanovector ASA today announces that Betalutin® (177Lu-satetraxetan-lilotomab) has been granted a Promising Innovative Medicine (PIM) designation by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment of patients with advanced relapsed/refractory follicular lymphoma (R/R FL).